The Skin Cancer Quality of Life Impact Tool (SCQOLIT): A validated health-related quality of life questionnaire for non-metastatic skin cancers

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 9, 2013, Pages 1109-1113

  Burdon Jones, D ^a   Gibbons, K ^b  

^a MATER ADULT HOSPITAL   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONSTRUCT VALIDITY; EMOTIONAL STABILITY; FEMALE; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; QUALITY OF LIFE INDEX; SKIN CANCER; SKIN CANCER QUALITY OF LIFE IMPACT TOOL; SOCIAL BEHAVIOR; TEST RETEST RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SKIN NEOPLASMS;

EID: 84881156902     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04669.x     Document Type: Article

References (16)

1. Both H, Essink-Bot ML, Busschbach J, Nijsten T,. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol 2007; 127: 2726-2739.
2. Trask PC, Paterson AG, Hayasaka S, et al. Psychosocial characteristics of individuals with non-stage 4 melanoma. J Clin Oncol 2001; 19: 2844-2850.
3. Rhee JS, Matthews A, Neuburg M, et al. Validation of a quality-of-life instrument for patients with non-melanoma skin cancer. Arch Facial Plast Surg 2006; 8: 314-318.
4. Rhee JS, Matthews A, Neuburg M, et al. The skin cancer index: clinical responsiveness and predictors for quality of life. Laryngoscope 2007; 117: 399-405.
5. Burdon-Jones D, Thomas P, Baker R,. Quality of life issues in non-metastatic skin cancer. Br J Dermatol 2010; 162: 147-151.
6. Cormier JN, Ross MI, Gerschenwald JE, et al. Prospective assessment of the reliability, validity and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer 2008; 112: 2249-2257.
7. Lear W, Akeroyd JE, Mittmann N, Murray C,. Measurement of utility in non-melanoma skin cancer. J Cutan Med Surg 2008; 12: 102-106.
8. Finlay AY, Khan GK,. The Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
9. Blackford S, Roberts D, Salek MS, Finlay AY,. Basal cell carcinomas cause little handicap. Qual Life Res 1996; 5: 191-194.
10. Norman GR, Sloan JA, Wyrwich KW,. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
11. Chen S,. Dermatology quality of life instruments: sorting out the quagmire. J Invest Dermatol 2007; 127: 2695-2696.
12. Holterhues C, Cornish D, van de Poll-Franse L V, et al. Impact of melanoma on patients' lives among 562 survivors: a Dutch population- based study. Arch Dermatol 2011; 147: 177-185.
13. Mazzotti E, et al. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 2005; 85: 409-413.
14. Nijsten TE, Meads DM, McKenna SP, Dimensionality of the Dermatology Life Quality Index (DLQI): a commentary. Acta Derm Venereol 2006; 86: 284-285.
15. Twiss J, Meads DM, Preston EP, et al. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012; 132: 76-84.
16. Rasch G,. (Reprinted 1980) Probabilistic Models for Some Intelligence and Attainment Tests. University of Chicago Press, Chicago, 1960.